Improving the quality of life and the possibility of pathogenetic therapy in adult patients with cerebral palsy

Antipenko E.A.; Shulyndin A.V.

doi:https://doi.org/10.17116/jnevro202512510175

Recommended articles:

Neurocytoprotection advances in reperfusion therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):75-88

Abobotulinumtoxin A injections for the chronic sialorrhea correction in children: Russian retrospective multicenter study. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):53-61

Arterial hypertension is an oxidative stress, as a pathogenetic target for the treatment of chronic cerebrovascular insufficiency. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):84-90

Aicardi—Goutieres syndrome type 6 associated with a compound heterozygous variant in ADAR: a first case report in the Russian population. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):131-138

Exercise therapy in outpatient rehabilitation programmes for patients with comorbid digestive pathology in colon cancer and chronic pancreatitis. (Open randomized controlled trial). Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6-2):5-12

Assessment of the quality of life of patients after dental surgeries using kinesiotaping and infrared laser therapy. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6-2):110-116

Possibilities of using meldonium as part of complex therapy in patients with ischemic heart disease and chronic heart failure combined with obesity. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(1):53-60

Psoriasis: analysis of comorbid pathology. Russian Journal of Clinical Dermatology and Venereology. 2025;(1):16-21

Nutrition correction in the complex therapy and rehabilitation of the posttraumatic stress disorder. Russian Journal of Preventive Medicine. 2025;(2):114-119

Digital dental approach in rehabilitation of a patient treated for unilateral ankylosis of a temporomandibular joint using condylotomy. Stomatology. 2025;(1):9-16

Abstract:

A large number of scientific studies have been devoted to the problem of cerebral palsy in children, the results of which have made it possible to create clinical diagnostic algorithms and specialized rehabilitation methods that are actively used In Russia and abroad. At the same time, much less attention is paid to the problem of cerebral palsy in patients over the age of 18. To date, questions about the clinical features of adult patients with various forms of cerebral palsy remain open, the frequency and features of the course of comorbid diseases, factors affecting the duration and quality of life in adults with cerebral palsy have not been sufficiently studied. The review examines the etiology and pathogenesis of cerebral palsy, discusses issues of diagnosis formulation, assessment of functioning, quality of life, comorbid and concomitant diseases in adult patients with cerebral palsy. The article provides up-to-date information on modern methods of non-drug and drug rehabilitation, as well as the role of neurocytoprotectors and the prospects associated with their use in patients with cerebral palsy over the age of 18.

Keywords:

cerebral palsy

functioning

comorbidity

quality of life

rehabilitation

neuroprotection

Mexidol

Authors:

Antipenko E.A.

Privolzhsky Research Medical University

SPIN RSCI: 7708-9068
Scopus AuthorID: 34871353400
ORCID: 0000-0002-8972-9150

Shulyndin A.V.

Privolzhsky Research Medical University

ORCID: 0000-0003-2822-9934

Received:

21.07.2025

Accepted:

22.07.2025

Close metadata

References:

The Union of Pediatricians of Russia. Clinical guidelines «Cerebral palsy», 2017. Date of request 07/20/2025. (In Russ.). Available from: https://rehabrus.ru/Docs/2017/06/KR_DPC.pdf
Federalnye klinicheskie rekomendatsii po detskoj nevrologii. Pod red. Guzevoi VI. SPb, OOO «Valetudo». 2023. (In Russ.).
Vitrikas K, Dalton H, Breish D. Cerebral palsy: An overview. Am Fam Phys. 2020;101(4):213-220.
Nemkova SA, Boldyrev VG. Early differential diagnosis and restorative treatment of cerebral palsy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(1):24-37. (In Russ.). https://doi.org/10.17116/jnevro202412401124
Health care In Russia. 2023: statistical collection Rosstat. M. Z-46 2023;179. (In Russ.). The reference is active on 20.07.25. https://rosstat.gov.ru/storage/mediabank/Zdravoohran-2023.pdf
Sadowska M, Sarecka B, Kopyta I. Cerebral palsy: current opinions on definition, epidemiology, risk factors, classification and treatment options. Neuropsyc Dis Treat. 2020;16:1505-1518. https://doi.org/10.2147/NDT.S235165
McIntyre S, Taitz D, Keogh J, et al. A systematic review of risk factors for cerebral palsy in children born at term in developed countries. Dev Med Child Neurol. 2013;55(6):499-508. https://doi.org/10.1111/dmcn.12017
Kirby RS. Cerebral palsy and birth defects: what is the frame of reference? Dev Med Child Neurol. 2012;54(8):677-678. https://doi.org/10.1111/j.1469-8749.2012.04331.x
Fahey M, Maclennan A, Kretzschmar D, et al. The genetic basis of cerebral palsy. Dev Med Child Neurol. 2017;59(5):462-469. https://doi.org/10.1111/dmcn.13363
Xue J, Xue L, Zhou Q. Meta-analysis of risk factors for childhood cerebral palsy during pregnancy. Dang Dai Er Ke Za Zhi. 2013;15(7):535-540. (In Chinese).
Basu AP. Early intervention after perinatal stroke: opportunities and challenges. Dev Med Child Neurol. 2014;56(6):516-521. https://doi.org/10.1111/dmcn.12407
Soleimani F, Vameghi R, Biglarian A. Antenatal and intrapartum risk factors for cerebral palsy in term and near-term newborns. Arch Iran Med. 2013;16(4):213-236.
Ahlin K, Himmelmann K, Hagberg G, et al. Non-infectious risk factors for different types of cerebral palsy in term-born babies: a population-based, case-control study. BJOG. 2013;120(6):724-731. https://doi.org/10.1111/1471-0528.12164
Upadhyay J, Tiwari N, Ansari MN. Cerebral palsy: Aetiology, pathophysiology and therapeutic interventions. Clin Exp Pharmacol Physiol. 2020;47(12):1891-1901. https://doi.org/10.1111/1440-1681.13379
Abdullahi H, Satti M, Rayis DA, et al. Intra-partum fever and cerebral palsy in Khartoum, Sudan. BMC Res Notes. 2013;6:163. https://doi.org/10.1186/1756-0500-6-163
McIntyre S, Taitz D, Keogh J, et al. A systematic review of risk factors for cerebral palsy in children born at term in developed countries. Dev Med Child Neurol. 2013;55(6):499-508. https://doi.org/10.1111/dmcn.12017
Ahlin K, Himmelmann K, Hagberg G, et al. Cerebral palsy and perinatal infection in children born at term. Obstet Gynecol. 2013;122(1):41-49. https://doi.org/10.1097/AOG.0b013e318297f37f
Jin S, Lewis S, Bakhtiari S, et al. Mutations disrupting neuritogenesis genes confer risk for cerebral palsy. Nat Genet. 2020;52(10):1046-1056. https://doi.org/10.1038/s41588-020-0695-1
Navarrete-Opazo AA, Gonzalez W, Nahuelhual P. Effectiveness of Oral Baclofen in the Treatment of Spasticity in Children and Adolescents With Cerebral Palsy. Arch Phys Med Rehabil. 2016;97(4):604-618. https://doi.org/10.1016/j.apmr.2015.08.417
MacLennan A, Thompson S, Gecz J. Cerebral palsy: causes, pathways, and the role of genetic variants. Am J Obstet Gynecol. 2015;213(6):779-788. https://doi.org/10.1016/j.ajog.2015.05.034
Ermolina YuV, Namazova-Baranova LS, Mamedyarov AM, et al. The Role of Diffusion-Tensor Magnetic Resonance Imaging and Tractography in the Diagnosis of Structural Brain Disorders in Children with Cerebral Palsy. Current Pediatrics. 2016;15(2):141-147. (In Russ.). https://doi.org/10.15690/vsp.v15i2.1531
Pal’chik AB, Shabalov NP. Toksicheskie entsefalopatii novorozhdennykh. M.: MEDpress-inform. 2012. (In Russ.).
McClelland VM, Lin JP. Sensorimotor Integration in Childhood Dystonia and Dystonic Cerebral Palsy-A Developmental Perspective. Front Neurol. 2021;12:668081. https://doi.org/10.3389/fneur.2021.668081
Monbaliu E, Himmelmann K, Lin JP, et al. Clinical presentation and management of dyskinetic cerebral palsy. Lancet Neurol. 2017;16(9):741-749. https://doi.org/10.1016/S1474-4422(17)30252-1
Levin OS, Illarioshkin SN, Golubev VL. Extrapyramidal syndromes: A guide for doctors. M.: MEDpress-inform. 2022;772. (In Russ.).
Prityko AG, Chebanenko NV, Sokolov PL, et al. Genetic Aspects of Pathogenesis of Congenital Spastic Cerebral Paralysis. Acta Biomedica Scientifica. 2019;4(3):28-39. (In Russ.). https://doi.org/10.29413/ABS.2019-4.3.4
Semenova KA. The problem of rehabilitation of children cerebral palsy. S.S. Korsakov Journal of Neurology and Psychiatry. 2012;112(7-2):9-13. (In Russ.).
Shulyndin AV, Komshina KS, Antipenko EA. Features of Motor Disorders in Adult Patients with Cerebral Palsy. Nervous Diseases. 2020;2:48-52. (In Russ.). https://doi.org/10.24411/2226-0757-2020-12185
Palisano R, Rosenbaum P, Walter S, et al. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 1997;39(4):214-223. https://doi.org/10.1111/j.1469-8749.1997.tb07414.x
Eliasson A, Krumlinde-Sundholm L, Rösblad B, et al. The Manual Ability Classification System (MACS) for children with cerebral palsy: scale development and evidence of validity and reliability. Dev Med Child Neurol. 2006;48(7):549-554.
Hidecker MJ, Paneth N, Rosenbaum PL, et al. Developing and validating the Communication Function Classification System for individuals with cerebral palsy. Dev Med Child Neurol. 2011;53(8):704-711. https://doi.org/10.1111/j.1469-8749.2011.03996.x
Paleg G, Livingstone R. Evidence-informed clinical perspectives on postural management for hip health in children and adults with non-ambulant cerebral palsy. J Pediatr Rehabil Med. 2022;15(1):39-48. https://doi.org/10.3233/PRM-220002
Paulson A, Vargus-Adams J. Overview of Four Functional Classification Systems Commonly Used in Cerebral Palsy. Children (Basel). 2017;4(4):30. https://doi.org/10.3390/children4040030
Dan B, Mayston M, Paneth N. Cerebral palsy: science and clinical practice. London: Mac Keith Press. 2014;692.
Flanigan M, Gaebler-Spira D, Kocherginsky M, et al. Spasticity and pain in adults with cerebral palsy. Dev Med Child Neurol. 2020;62(3):379-385. https://doi.org/10.1111/dmcn.14368
Shulyndin AV. Features of motor disorders in adult patients with cerebral palsy: specialty 14.01.11 «Nervous diseases»: Diss. ... cand. med. sciences. 2022. (In Russ.).
Kurenkov AL, Bursagova BI, Artemenko AR. Assessment of spasticity-related pain in cerebral palsy and the efficacy of its treatment with incobotulinumtoxin A. Nevrologiya, Neiropsikhiatriya, Psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2024;16(1):94-101. (In Russ.). https://doi.org/10.14412/2074-2711-2024-1-94-101
Kislyakova EA, Timoshenkova UM. The influence of cognitive and motor impairments on the quality of life of adult patients with cerebral palsy. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119 (5-2):335. (In Russ.).
Van der Slot WMA, Benner JL, Brunton L, et al. Pain in adults with cerebral palsy: A systematic review and meta-analysis of individual participant data. Ann Phys Rehabil Med. 2021;64(3):101359. https://doi.org/10.1016/j.rehab.2019.12.011
Pérez IF, Villagra TB, Jiménez-Balado J, et al. Risk factors and outcome of epilepsy in adults with cerebral palsy or intellectual disability. Epilepsy Behav. 2023;147:109450. https://doi.org/10.1016/j.yebeh.2023.109450
Ivanova GE, Melnikova EV, Shmonin AA, et al. Pilot project «Development of the medical rehabilitation system in the Russian Federation». Protocol of the second phase Scientific notes of Pavlov St. Petersburg State Medical University. 2016;23(2):27-34. (In Russ.).
Belova AN, Sheiko GE, Shalkunova NV. Medical rehabilitation in cerebral palsy: application of the international classification of functioning, disability and health of children and adolescents. Bulletin of Restorative Medicine. 2019;1:2-9. (In Russ.).
Noten S, Selb M, Troenosemito LAA, et al.; ICF Core Set for Adults with CP Consensus Group. ICF Core Sets for the assessment of functioning of adults with cerebral palsy. Dev Med Child Neurol. 2022;64(5):569-577. https://doi.org/10.1111/dmcn.15104
Benner JL, Noten S, Limsakul C, et al. Outcomes in adults with cerebral palsy: systematic review using International Classification of Functioning, Disability and Health. Dev Med Child Neurol. 2019;61(10):1153-1161. https://doi.org/10.1111/dmcn.14247
Shulyndin AV, Antipenko EA. Specific features of rehabilitation potential in adult patients with cerebral palsy. Saratov J Med Sci Res. 2019;15(1):187-190. (In Russ.).
Langan J, Kern KL, Hurvitz EA, et al. Upper-limb position sense deficits in adults with cerebral palsy. Am J Phys Med Rehabil. 2014;93(9):774-781. https://doi.org/10.1097/PHM.0000000000000100
Verhoef JA, Bramsen I, Miedema HS, et al.Transition and Lifespan Research Group South West Netherlands. Development of work participation in young adults with cerebral palsy: a longitudinal study. J Rehabil Med. 2014;46(7):648-655. https://doi.org/10.2340/16501977-1832
Tsujimura H, Taoda K, Kitahara T. Effectual points of view in occupational health management for persons with cerebral palsy — interventional case approach in VDT work. Ind Health. 2011;49(3):297-310. https://doi.org/10.2486/indhealth.ms1217
Caron JG, Light J. Social media experiences of adolescents and young adults with cerebral palsy who use augmentative and alternative communication. Int J Speech Lang Pathol. 2017;19(1):30-42. https://doi.org/10.3109/17549507.2016.1143970
Maestro-Gonzalez A, Cruz Bilbao-Leon M, Zuazua-Rico D, et al. Quality of life as assessed by adults with cerebral palsy. Plos One. 2018;13(2):e0191960. https://doi.org/10.1371/journal.pone.0191960
Colver A, Fairhurst C, Pharoah P. Cerebral palsy. Lancet. 2014;383(9924): 1240401249. https://doi.org/10.1016/S0140-6736(13)61835-8
Kingsnorth S. A retrospective study of past graduates of a residential life skills program for youth with physical disabilities. Child Care Health Dev. 2015;41(3):374-383. https://doi.org/10.1111/cch.12196
Garin N, Olaya B, Moneta MV, et al. Impact of multimorbidity on disability and quality of life in the Spanish older population. PloS One. 2014;9(11):e111498. https://doi.org/10.1371/journal.pone.0111498
Nooijen C, Slaman J, Stam HJ. Inactive and sedentary lifestyles amongst ambulatory adolescents and young adults with cerebral palsy. J NeuroEngineering Rehab. 2014;11:49. https://doi.org/10.1186/1743-0003-11-49
Klochkova OA, Kurenkov AL. Muscular Weakness and Loss of Motor Skills in Patients with Cerebral Palsy. Current Pediatrics. 2020;19(2):107-115. (In Russ.). https://doi.org/10.15690/vsp.v19i2.2103
Hilberink SR. The Whitney Comorbidity Index for adults with cerebral palsy: a challenge for practice. Dev Med Child Neurol. 2021;63(7):767. https://doi.org/10.1111/dmcn.14890
van der Slot WM, Roebroeck ME, Nieuwenhuijsen C, et al. MoveFit and Lifespan Research Group. Cardiovascular disease risk in adults with spastic bilateral cerebral palsy. J Rehabil Med. 2013;45(9):866-872. https://doi.org/10.2340/16501977-1185
Mcphee PG, Claridge EA, Noorduyn SG, Gorter JW. Cardiovascular disease and related risk factors in adults with cerebral palsy. Dev Med Child Neurol. 2019;61(8):915-923. https://doi.org/10.1111/dmcn.14028
Leis AM, Hurvitz EA, Whitney DG. Comorbidity Clusters Among Adults With Cerebral Palsy: A Latent Class Analysis. Am J Prev Med. 2024;66(6):971-979. https://doi.org/10.1016/j.amepre.2024.01.011
Whitney DG, Kamdar NS. Development of a new comorbidity index for adults with cerebral palsy and comparative assessment with common comorbidity indices. Dev Med Child Neurol. 2021;63(3):313-319. https://doi.org/10.1111/dmcn.14759
Himmelmann K, Sundh V. Survival with cerebral palsy over five decades in western Sweden. Dev Med Child Neurol. 2015;57(8):762-767. https://doi.org/10.1111/dmcn.12718
Shah S, Bradbury-Jones C, Taylor J. Using Facebook to tell stories of premature ageing and sexual and reproductive healthcare across the life course for women with cerebral palsy in the UK and USA. BMJ Open. 2020;10(2):e032172. https://doi.org/10.1136/bmjopen-2019-032172
Diaz Heijtz R, Forssberg H. Translational studies exploring neuroplasticity associated with motor skill learning and the regulatory role of the dopamine system. Dev Med Child Neurol. 2015;57 Suppl 2:10-14. https://doi.org/10.1111/dmcn.12692
Björquist E, Nordmark E, Hallström I. Living in transition — experiences of health and well-being and the needs of adolescents with cerebral palsy. Child Care Health Dev. 2015;41(2):258-265. https://doi.org/10.1111/cch.12151
Langan J. Upper-Limb Position Sense Deficits in Adults with Cerebral Palsy. Am J Phys Med Rehabil. 2014;93(9):774-781. https://doi.org/10.1097/PHM.0000000000000100
Gasior JS, Jelen P. Strength training as a form of rehabilitation in adults with cerebral palsy. Aktualn Neurol. 2016;16(1):29-36. https://doi.org/10.15557/AN.2016.0005
Huang IC, Holzbauer JJ, Lee EJ, et al. Vocational rehabilitation services and employment outcomes for adults with cerebral palsy in the United States. Dev Med Child Neurol. 2013;55(11):1000-1008. https://doi.org/10.1111/dmcn.12224
Kim SJ, Kwak EE, Park ES, et al. Changes in gait patterns with rhythmic auditory stimulation in adults with cerebral palsy. NeuroRehabilitation. 2011;29(3):233-241. https://doi.org/10.3233/NRE-2011-0698
Flamand VH, Schneider C. Noninvasive and painless magnetic stimulation of nerves improved brain motor function and mobility in a cerebral palsy case. Arch Phys Med Rehabil. 2014;95(10):1984-1990. https://doi.org/10.1016/j.apmr.2014.05.014
Auvichayapat P, Aree-Uea B, Auvichayapat N, et al. Transient Changes in Brain Metabolites after Transcranial Direct Current Stimulation in Spastic Cerebral Palsy: A Pilot Study. Front Neurol. 2017;8:366. https://doi.org/10.3389/fneur.2017.00366
Dickin DC, Faust KA, Wang H, Frame J. The acute effects of whole-body vibration on gait parameters in adults with cerebral palsy. J Musculoskelet Neur Int. 2013;13(1):19-26.
Monbaliu E, de Cock P, Ortibus E, et al.Clinical patterns of dystonia and choreoathetosis in participants with dyskinetic cerebral palsy. Dev Med Child Neurol. 2016;58(2):138-144. https://doi.org/10.1111/dmcn.12846
Langerak NG, Hillier SL, Verkoeijen PP, et al. Level of activity and participation in adults with spastic diplegia 17-26 years after selective dorsal rhizotomy. J Rehabil Med. 2011;43(4):330-337. https://doi.org/10.2340/16501977-0669
Klochkova OA, Kurenkov AL, Namazova-Baranova LS, et al. The Concept of «Key Muscles» and the Early Onset of Botulinum Therapy in Spastic Forms of Cerebral Palsy. Current Pediatrics. 2017;16(1):39-48. (In Russ.). https://doi.org/10.15690/vsp.v16i1.1693
Mihai EE, Popescu MN, Iliescu AN, Berteanu M. A systematic review on extracorporeal shock wave therapy and botulinum toxin for spasticity treatment: a comparison on efficacy. Eur J Phys Rehabil Med. 2022;58(4):565-574. https://doi.org/10.23736/S1973-9087.22.07136-2
Blackman JA, Conaway MR. Adolescents with cerebral palsy: transitioning to adult health care services. Clin Pediatr (Phila). 2014;53(4):356-363. https://doi.org/10.1177/0009922813510203
Eek MN, Olsson K, Lindh K, et al. Intrathecal baclofen in dyskinetic cerebral palsy: effects on function and activity. Dev Med Child Neurol. 2018;60(1):94-99. https://doi.org/10.1111/dmcn.13625
Harvey A, Reddihough D, Scheinberg A, Williams K. Oral medication prescription practices of tertiary-based specialists for dystonia in children with cerebral palsy. J Paediatr Child Health. 2018;54(4):401-404. https://doi.org/10.1111/jpc.13754
Patent No. 2752511 C1 Russian Federation, IPC A61B 5/00. Method for assessing the effectiveness of rehabilitation of adult patients with cerebral palsy: No. 2020112926: application 04.04.2020: published 28.07.2021. EA Antipenko, AV Shulyndin, KS Komshina; applicant Federal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» Ministry of Health of the Russian Federation. (In Russ.).
Koval’chuk-Kovalevskaya OV, Evsyukova II. The use of neuroprotection in the treatment of newborn children with functional development of the central nervous system. Pediatriya. 2012;91:6:129-134. (In Russ.).
Kholin AA, Zavadenko NN, Esipova ES. Cerebral palsy and epilepsy. Issues of practical pediatrics. 2016;11(4):66-72. (In Russ.). https://doi.org/10.20953/1817-7646-2016-4-66-72
Nemkova SA. Mental impairment in children with cerebral palsy: diagnosis and treatment. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(2):105-113. (In Russ.). https://doi.org/10.17116/jnevro201811821105-113
Voronina TA, Litvinova SA, Gladysheva NA. The known and new ideas about the mechanism of action and the spectrum of effects of Mexidol. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(5):22-33. (In Russ.). https://doi.org/10.17116/jnevro202512505122
Miroshnichenko II, Smirnov LD, Voronin AE, et al. The effect of Mexidol on the content of mediator monoamines and amino acids in rat brain structures. Bulletin of Experimental Biology and Medicine. 1996;2:170-172. (In Russ.).
Shchulkin AV, Chernykh IV, Abalenikhina YuV, et al. The effect of Mexidol on the level of neurogenesis markers in acute cerebrovascular accident in the experiment. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(2):107-112. (In Russ.). https://doi.org/10.17116/jnevro2025125021107
Stakhovskaya LV, Shamalov NA, Khasanova DR, et al. Results of a randomized double blind multicenter placebo-controlled, in parallel groups trial of the efficacy and safety of prolonged sequential therapy with mexidol in the acute and early recovery stages of hemispheric ischemic stroke (EPICA). S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(3-2):55-65. (In Russ.). https://doi.org/10.17116/jnevro20171173255-65
Fedin AI, Zakharov VV, Tanashyan MM, et al. Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO). S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(11):7-16. (In Russ.). https://doi.org/10.17116/jnevro20211211117
Zavadenko NN, Suvorinova NYu, Batysheva TT, et al. Results of a multicentre double-blind randomised placebo-controlled clinical trial evaluating the efficacy and safety of Mexidol in the treatment of Attention Deficit Hyperactivity Disorder in Children (MEGA). S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(4):75-86. (In Russ.). https://doi.org/10.17116/jnevro202212204175
Martynov AI, Tanashyan MM, Malyavin AG, et al. Resolution of the Expert Council «Possibilities of neuroprotective therapy in patients with arterial hypertension and cognitive disorders». Therapy. 2023;9(10):148-158. (In Russ.). https://doi.org/10.18565/therapy.2023.10.148-158
Tanashyan MM, Malyavin AG, Antonova KV, et al.Cerebrovascular disease in clinical practice. Resolution of the Expert Council of the Russian Scientific Medical Society of Therapists. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(6):105-111. (In Russ.). https://doi.org/10.17116/jnevro2025125061105
Shchulkin AV, Kazakhmedov ER, Galochkin SA, et al. Effects of mexidol in patients with chronic brain ischemia and chronic heart failure (II—III functional class). Russian Journal of Cardiology and Cardiovascular Surgery. 2020;13(5):427-434. (In Russ.). https://doi.org/10.17116/kardio202013051427